UY30411A1 - Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones - Google Patents
Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicacionesInfo
- Publication number
- UY30411A1 UY30411A1 UY30411A UY30411A UY30411A1 UY 30411 A1 UY30411 A1 UY 30411A1 UY 30411 A UY30411 A UY 30411A UY 30411 A UY30411 A UY 30411A UY 30411 A1 UY30411 A1 UY 30411A1
- Authority
- UY
- Uruguay
- Prior art keywords
- pirimidin
- amina
- tetrahydroimidazo
- acetate
- applications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
La presente invencion se refiere a nuevos compuestos que tienen la formula estructural I que figura a continuacion: y su sal farmacéuticamente aceptable, composiciones y métodos de uso. Estos compuestosproporcionan un tratamiento o profilaxis del impedimento cognitivo, el mal de Alzheimer, degeneracion neurologica y demencia.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81354906P | 2006-06-14 | 2006-06-14 | |
US86645106P | 2006-11-20 | 2006-11-20 | |
US89698607P | 2007-03-26 | 2007-03-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30411A1 true UY30411A1 (es) | 2008-01-31 |
Family
ID=38831994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30411A UY30411A1 (es) | 2006-06-14 | 2007-06-13 | Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones |
Country Status (16)
Country | Link |
---|---|
US (1) | US20070299087A1 (es) |
EP (1) | EP2035425A1 (es) |
JP (1) | JP2009539975A (es) |
KR (1) | KR20090031564A (es) |
AR (1) | AR061371A1 (es) |
AU (1) | AU2007259432A1 (es) |
BR (1) | BRPI0712731A2 (es) |
CA (1) | CA2654403A1 (es) |
CL (1) | CL2007001732A1 (es) |
EC (1) | ECSP088969A (es) |
IL (1) | IL195574A0 (es) |
MX (1) | MX2008015587A (es) |
NO (1) | NO20090166L (es) |
TW (1) | TW200808796A (es) |
UY (1) | UY30411A1 (es) |
WO (1) | WO2007145570A1 (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700603B2 (en) * | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7763609B2 (en) * | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
AR050184A1 (es) * | 2004-07-28 | 2006-10-04 | Schering Corp | Inhibidores macrociclicos de beta-secretasa |
TWI332005B (en) * | 2005-06-14 | 2010-10-21 | Schering Corp | Aspartyl protease inhibitors |
US8722708B2 (en) * | 2005-06-14 | 2014-05-13 | Merck Sharp & Dohme Inc. | Substituted isoindolines as aspartyl protease inhibitors |
TW200815349A (en) | 2006-06-22 | 2008-04-01 | Astrazeneca Ab | New compounds |
CA2672295A1 (en) * | 2006-12-12 | 2008-06-19 | Schering Corporation | Aspartyl protease inhibitors containing a tricyclic ring system |
WO2008073365A1 (en) | 2006-12-12 | 2008-06-19 | Schering Corporation | Aspartyl protease inhibitors |
AU2009239535A1 (en) * | 2008-04-22 | 2009-10-29 | Schering Corporation | Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
WO2010056195A1 (en) * | 2008-11-14 | 2010-05-20 | Astrazeneca Ab | New compounds 575 |
US20100125081A1 (en) * | 2008-11-14 | 2010-05-20 | Astrazeneca Ab | New compounds 574 |
TW201020244A (en) | 2008-11-14 | 2010-06-01 | Astrazeneca Ab | New compounds |
KR20110136826A (ko) * | 2009-03-26 | 2011-12-21 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 신규의 인지기능장해 치료제 |
EP2485590B1 (en) | 2009-10-08 | 2015-01-07 | Merck Sharp & Dohme Corp. | Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use |
US8569310B2 (en) | 2009-10-08 | 2013-10-29 | Merck Sharp & Dohme Corp. | Pentafluorosulfur imino heterocyclic compounds as BACE-1 inhibitors, compositions and their use |
UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
US8563543B2 (en) | 2009-10-08 | 2013-10-22 | Merck Sharp & Dohme Corp. | Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
WO2012138734A1 (en) | 2011-04-07 | 2012-10-11 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
WO2012138590A1 (en) | 2011-04-07 | 2012-10-11 | Merck Sharp & Dohme Corp. | Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
BR112014004181A2 (pt) | 2011-08-22 | 2017-06-13 | Merck Sharp & Dohme | composto, composição farmacêutica, e, método de tratamento, prevenção, e / ou retardo do início de uma doença ou patologia |
AU2013235422B2 (en) | 2012-03-19 | 2016-12-15 | Buck Institute For Research On Aging | APP specific BACE inhibitors (ASBIs) and uses thereof |
EP2908824B1 (en) | 2012-10-17 | 2018-05-02 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
WO2014062549A1 (en) | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
EP2956443B1 (en) | 2013-02-12 | 2019-09-25 | Buck Institute For Research On Aging | Hydantoins that modulate bace-mediated app processing |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008503460A (ja) * | 2004-06-16 | 2008-02-07 | ワイス | β−セクレターゼのインヒビターとしてのジフェニルイミダゾピリミジンおよびイミダゾールアミン |
JP2008526966A (ja) * | 2005-01-14 | 2008-07-24 | ワイス | β−セクレターゼの阻害のためのアミノ−イミダゾロン |
-
2007
- 2007-06-04 TW TW096119991A patent/TW200808796A/zh unknown
- 2007-06-11 US US11/761,131 patent/US20070299087A1/en not_active Abandoned
- 2007-06-12 KR KR1020097000708A patent/KR20090031564A/ko not_active Application Discontinuation
- 2007-06-12 BR BRPI0712731-6A patent/BRPI0712731A2/pt not_active Application Discontinuation
- 2007-06-12 MX MX2008015587A patent/MX2008015587A/es not_active Application Discontinuation
- 2007-06-12 WO PCT/SE2007/000573 patent/WO2007145570A1/en active Application Filing
- 2007-06-12 JP JP2009515346A patent/JP2009539975A/ja active Pending
- 2007-06-12 AU AU2007259432A patent/AU2007259432A1/en not_active Abandoned
- 2007-06-12 EP EP07748236A patent/EP2035425A1/en not_active Withdrawn
- 2007-06-12 CA CA002654403A patent/CA2654403A1/en not_active Abandoned
- 2007-06-13 CL CL2007001732A patent/CL2007001732A1/es unknown
- 2007-06-13 AR ARP070102596A patent/AR061371A1/es unknown
- 2007-06-13 UY UY30411A patent/UY30411A1/es not_active Application Discontinuation
-
2008
- 2008-11-27 IL IL195574A patent/IL195574A0/en unknown
- 2008-12-12 EC EC2008008969A patent/ECSP088969A/es unknown
-
2009
- 2009-01-12 NO NO20090166A patent/NO20090166L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR061371A1 (es) | 2008-08-20 |
CL2007001732A1 (es) | 2008-01-25 |
US20070299087A1 (en) | 2007-12-27 |
IL195574A0 (en) | 2009-09-01 |
WO2007145570A9 (en) | 2008-12-11 |
KR20090031564A (ko) | 2009-03-26 |
MX2008015587A (es) | 2009-01-09 |
TW200808796A (en) | 2008-02-16 |
EP2035425A1 (en) | 2009-03-18 |
ECSP088969A (es) | 2009-01-30 |
BRPI0712731A2 (pt) | 2012-10-02 |
WO2007145570A1 (en) | 2007-12-21 |
NO20090166L (no) | 2009-03-12 |
CA2654403A1 (en) | 2007-12-21 |
JP2009539975A (ja) | 2009-11-19 |
AU2007259432A1 (en) | 2007-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30411A1 (es) | Derivados sustituidos del acetato de 2,3,4,-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones | |
UY30414A1 (es) | Metano sulfonatos, propano-1-sulfonatos y ciclopropan sulfonatos sustituidos con [2,3,4,8-tetrahidroimidazo-[1,5-al-pirimidin-8-il]-fenilo, composiciones farmacéuticas conteniéndolos y aplicaciones. | |
UY30407A1 (es) | Derivados de [2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-8-il]-fenil sulfonatos sustituidos, composiciones farmacéuticas y aplicaciones. | |
ECSP088499A (es) | Nuevos compuestos de 2-amino-imidazol-4-ona y su uso en la fabricación de un medicamento para uso en el tratamiento de alteración cognitiva, enfermedad de alzheimer, neurodegeneración y demencia | |
UY30408A1 (es) | Derivados sustituidos del acetato de 8-(4-metoxifenil)-2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones | |
ATE517882T1 (de) | Chinolinderivate | |
EA200901373A1 (ru) | Аминогетероциклические соединения | |
MX2012007273A (es) | Pteridinonas como inhibidores de la quinasa tipo polo. | |
ECSP088902A (es) | Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios | |
UY30812A1 (es) | Sulfonatos { 2-amino-4-[r-fenil]-1-metil-5-oxo-4,5-dihidro-1 h-imidazol-4-il}fenil sustituidos, composiciones conteniéndolos y aplicaciones | |
PA8627201A1 (es) | Compuestos de imidazol para el tratamiento de trastornos neurodegenerativos | |
ECSP077424A (es) | Derivados de quinuclidina y su uso como antagonistas del receptor muscarínico m3 | |
PE20151722A1 (es) | Derivados de pirimidona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral | |
CR10383A (es) | Derivados triazolopirazina. | |
TW200716596A (en) | Substituted amide derivatives and methods of use | |
DOP2006000169A (es) | Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
UY30274A1 (es) | Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones | |
DE602006006712D1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
ATE440834T1 (de) | Substituierte arylaminderivate und verwendungsverfahren | |
BR112014029016A8 (pt) | derivados de ácido 7-oxo-tiazolopiridina carbônico e seu uso no tratamento, melhora ou prevenção de uma doença viral | |
UY30377A1 (es) | Inhibidores triciclicos fusionados de sulfonamida de gama-secretasa | |
TW200637817A (en) | 5-aminoindole derivatives | |
DE602004008959D1 (de) | Benzoäbüä1,4üdioxepinderivate | |
PA8603001A1 (es) | Compuestos utiles para el tratamiento de enfermedades |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20170711 |